Insulin degludec Subcutaneous and Larotrectinib Sulfate
Determining the interaction of Insulin degludec Subcutaneous and Larotrectinib Sulfate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec Subcutaneous-Lartruvo
- Insulin degludec Subcutaneous-Larynex
- Insulin degludec Subcutaneous-Laryng-O-Jet
- Insulin degludec Subcutaneous-Laryngesic
- Insulin degludec Subcutaneous-Lasix
- Insulin degludec Subcutaneous-Lasix Injection
- Larotrectinib Sulfate-Insulin detemir
- Larotrectinib Sulfate-Insulin Detemir (Cartridges and Prefilled Syringes)
- Larotrectinib Sulfate-Insulin Detemir (Vials)
- Larotrectinib Sulfate-Insulin detemir Subcutaneous
- Larotrectinib Sulfate-Insulin glargine
- Larotrectinib Sulfate-Insulin Glargine (U-100) Cartridge Systems and Pens